Literature DB >> 31059632

Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Michael F Green1,2,3, William P Horan1,2,3, Junghee Lee1,2,3.   

Abstract

Cognitive impairment in schizophrenia involves a broad array of nonsocial and social cognitive domains. It is a core feature of the illness, and one with substantial implications for treatment and prognosis. Our understanding of the causes, consequences and interventions for cognitive impairment in schizophrenia has grown substantially in recent years. Here we review a range of topics, including: a) the types of nonsocial cognitive, social cognitive, and perceptual deficits in schizophrenia; b) how deficits in schizophrenia are similar or different from those in other disorders; c) cognitive impairments in the prodromal period and over the lifespan in schizophrenia; d) neuroimaging of the neural substrates of nonsocial and social cognition, and e) relationships of nonsocial and social cognition to functional outcome. The paper also reviews the considerable efforts that have been directed to improve cognitive impairments in schizophrenia through novel psychopharmacology, cognitive remediation, social cognitive training, and alternative approaches. In the final section, we consider areas that are emerging and have the potential to provide future insights, including the interface of motivation and cognition, the influence of childhood adversity, metacognition, the role of neuroinflammation, computational modelling, the application of remote digital technology, and novel methods to evaluate brain network organization. The study of cognitive impairment has provided a way to approach, examine and comprehend a wide range of features of schizophrenia, and it may ultimately affect how we define and diagnose this complex disorder.
© 2019 World Psychiatric Association.

Entities:  

Keywords:  Schizophrenia; brain network organization; childhood adversity; cognition; cognitive enhancement; cognitive neuroscience; cognitive remediation; computational modelling; functional outcome; metacognition; social cognition; social neuroscience

Year:  2019        PMID: 31059632      PMCID: PMC6502429          DOI: 10.1002/wps.20624

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  224 in total

1.  Cognitive correlates of job tenure among patients with severe mental illness.

Authors:  James M Gold; Richard W Goldberg; Scot W McNary; Lisa B Dixon; Anthony F Lehman
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

2.  Segmental set.

Authors:  D SHAKOW
Journal:  Arch Gen Psychiatry       Date:  1962-01

3.  Dysfunction of early-stage visual processing in schizophrenia.

Authors:  P D Butler; I Schechter; V Zemon; S G Schwartz; V C Greenstein; J Gordon; C E Schroeder; D C Javitt
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 4.  Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

Authors:  P D Harvey; R S Keefe
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

5.  Social cognition and the human brain.

Authors: 
Journal:  Trends Cogn Sci       Date:  1999-12       Impact factor: 20.229

6.  Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging.

Authors:  J I Friedman; P D Harvey; T Coleman; P J Moriarty; C Bowie; M Parrella; L White; D Adler; K L Davis
Journal:  Am J Psychiatry       Date:  2001-09       Impact factor: 18.112

Review 7.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Authors:  M F Green; R S Kern; D L Braff; J Mintz
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

8.  Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort.

Authors:  John Stirling; Colin White; Shon Lewis; Richard Hopkins; Digby Tantam; Alice Huddy; Linda Montague
Journal:  Schizophr Res       Date:  2003-12-15       Impact factor: 4.939

9.  Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity.

Authors:  Joseph I Friedman; Philip D Harvey; Susan R McGurk; Leonard White; Michael Parrella; Tenko Raykov; Thomas Coleman; David N Adler; Kenneth L Davis
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112

10.  The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

Authors:  Michael F Green; Stephen R Marder; Shirley M Glynn; Susan R McGurk; William C Wirshing; Donna A Wirshing; Robert P Liberman; Jim Mintz
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382

View more
  94 in total

1.  Cognitive impairment as a diagnostic criterion and treatment target in schizophrenia.

Authors:  Michael Davidson
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

2.  Why are there no approved treatments for cognitive impairment in schizophrenia?

Authors:  Richard S E Keefe
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

3.  Cognition and disability in schizophrenia: cognition-related skills deficits and decision-making challenges add to morbidity.

Authors:  Philip D Harvey; Martin T Strassnig
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

4.  Cognition in schizophrenia: a marker of underlying neurodevelopmental problems?

Authors:  Ingrid Melle
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

5.  The meaning of group differences in cognitive test performance.

Authors:  Paul M Grant; Michael W Best; Aaron T Beck
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

6.  Cognitive impairment and psychosis in schizophrenia: independent or linked conditions?

Authors:  Abraham Reichenberg; Eva Velthorst; Michael Davidson
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

7.  Innovative methods for improving cognition, motivation and wellbeing in schizophrenia.

Authors:  Barbara J Sahakian; George Savulich
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

8.  Nonsocial and social cognitive function in psychosis: interrelationships, specificity and innovative approaches.

Authors:  Deanna M Barch
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

9.  The need to develop personalized interventions to improve cognition in schizophrenia.

Authors:  Peter Falkai; Andrea Schmitt
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

10.  Mentalizing Errors in Patients with Schizophrenia Who Received Psychosocial Rehabilitation: a Case-Control Study.

Authors:  Nelson Andrade-González; Miriam Sarasa; Araceli García-López; Israel Leonés; Tate F Halverson; Guillermo Lahera
Journal:  Psychiatr Q       Date:  2021-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.